Results 151 to 160 of about 6,257 (206)

The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis. [PDF]

Cells
Martinez Salazar A, Mokhtari S, Peguero E, Jaffer M.   +3 more
europepmc   +1 more source

Guianensin, a Blackfly Salivary Protein, Inhibits the Lectin Pathway of Complement. [PDF]

J Med Chem
Valenzuela Leon PC, Ring ME, Nishiduka E, Bonilla B, Cruz P, Martinez EP, Percopo C, Calvo E.   +7 more
europepmc   +1 more source

Candidiasis: Insights into Virulence Factors, Complement Evasion and Antifungal Drug Resistance. [PDF]

Microorganisms
Gaffar NR, Valand N, Venkatraman Girija U.   +2 more
europepmc   +1 more source

Rapid and sensitive identification of <i>Candida</i> in blood based on M1 beads enrichment combined with multiple recombinase-aided PCR: a culture-independent approach. [PDF]

Front Cell Infect Microbiol
Wang Y, Chen X, Peng K, Tie Y, Gao Y, Han Z, Lyu X, Li H, Zhang R, Gao S, Shen X, Ma X, Feng Z.   +12 more
europepmc   +1 more source

Translating biomarker insights into practice: a path forward in TA-TMA management. [PDF]

Front Med (Lausanne)
Jodele S, Gavriilaki E.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Quantification of mannan-binding lectin

Journal of Immunological Methods, 2006
Mannan-binding lectin (MBL) is attracting considerable interest due to its role in the immune defense. The high frequency of congenital MBL deficiency makes it feasible to evaluate clinical relevance through epidemiological investigations on fairly limited numbers of patients.
Frederiksen, Pernille D, Thiel, Steffen, Jensen, Lisbeth, Hansen, Annette G, Matthiesen, Finn, Jensenius, Jens Christian   +5 more
openaire   +4 more sources

Mannan-binding lectin in malignancy

Molecular Immunology, 2013
Complement may play a dual role in cancer: it may contribute either to the development or to the inhibition of tumour growth. Its components may be candidate biomarkers facilitating the disease detection, its progress or effectiveness of therapy. Additionally, complement deficiencies may increase the risk of infections and contribute to the higher ...
Anna St. Swierzko, David C. Kilpatrick, Maciej Cedzynski   +2 more
openaire   +3 more sources

Mannan-Binding lectin in asthma and allergy

Current Allergy and Asthma Reports, 2006
Mannan-binding lectin (MBL) is a vital and versatile component of innate immunity. It is present in serum and may bind to a plethora of microbial pathogens and mediate opsonization of these by complement-dependent and/or independent mechanisms. Low-MBL levels in serum, attributed to certain genetic polymorphisms, constitute a major factor predisposing ...
Kaur, S., Thiel, Steffen, Sarma, P.U., Madan, T.   +3 more
openaire   +5 more sources

Assays for the Mannan‐Binding Lectin Pathway

Current Protocols in Immunology, 2003
AbstractThis unit contains protocols that can be used to measure mannan‐binding lectin (MBL) levels and MBL pathway activity in human plasma or serum. Using a modification of the conventional ELISA, the detection reagent used in the methods described (e.g., an antibody or streptavidin) is labeled with Eu3+ instead of an enzyme.
Gadjeva, Mihaela, Thiel, Steffen, Jensenius, Jens Christian   +2 more
openaire   +3 more sources